News 12.09.17

Exciting new hits for a novel drug target involved in depression and pain unveiled in the European Lead Factory project

ioneering ideas to improve antidepressant therapies are greatly required since existing antidepressants are moderately effective and the response rate in patients suffering from depression is approximately less than 50%.

Read more
News 31.05.17

NCardia partners with Pivot Park Screening Centre to offer ultra High Throughput Screening for Cardiovascular drug discovery services

NCardia and Pivot Park Screening Centre announced a collaboration to improve NCardia's cardiovascular drug discovery service offerings and to expand Pivot Park Screening Centre’s knowledge about new and innovative assay technologies used to accelerate drug discoveries.

Read more
News 28.02.17

Committed to strengthening the antibiotic arsenal

The European Lead Factory (ELF) is boosting the discovery of new drugs by making high throughput screening and a quality compound library available to academia and biotech’s.

Read more
News 12.12.16

COILED open innovation centre launched

COILED, Center for Open Innovation in LEad Discovery, is a new public-private open innovation centre focused on the early phase of pharmaceutical drug development. Pivot Park Screening Centre is one of the open innovation centre's partners.

Read more
News 21.11.16

Promising antibiotic programme gets European boost

Innovative Medicines Initiative (IMI) projects European Lead Factory (ELF) and ENABLE create pipeline for novel antibiotics from University of Oxford. The ultra High Throughput Screening for this project has been carried out by Pivot Park Screening Centre, the European Screening Centre within ELF.

Read more
News 03.10.16

EU Lead Factory Results: The Fast Facts

The European Lead Factory is a unique public-private partnership that promotes new discoveries via open innovation and crowd sourcing. It was established to promote the discovery of novel small molecule candidates, suitable for subsequent optimisation either to drug candidates or to high-quality pharmacological tools for the experimental validation of targets.

Read more
News 25.08.16

ZeGlobalTox – a rapid and reliable preclinical screening tool

The zebrafish (Danio rerio) is a tropical fish with a genetic structure surprisingly similar to ours. However, they’ve become a popular model organism only relatively recently.

Read more
News 05.07.16

Pivot Park Screening Centre (PPSC) and Dutch Techcentre for Life sciences (DTL) start partnership

PPSC helps to find new starting points for development of medicines by providing Ultra High Throughput Screening services. This is a technology in which large quantities of data are generated.

Read more
News 21.05.15

Pivot Park Screening Centre to participate in pilot for Zebrafish neurotoxicity assay

ZeClinics (Spain), Noldus (Netherlands) and Pivot Park Screening Centre (Netherlands) will work together in project ZeGlobalTox to make the translation for neurotoxicity testing in zebrafish.

Read more
  • 1
  • 2